Fritextsökning
Innehållstyper
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Utför miljardköp av företag i kontanter
Johnson & Johnson köper Alios Biopharma för närmare 13 miljarder kronor, i kontanter.
-
Diamyd förlikar i licenstvist
Ger University of Florida en del av ersättningen de fick från affären med Ortho-McNeil-Janssen.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Robotlabb som automatiserar allt
Transcriptic är ett nytt koncept och finns tillgängligt som en service. är ett robotiserat start-up företag som ska göra livet på labbet enklare för användaren.
-
De får högst forskningsbidrag av Vetenskapsrådet
Jan Nilsson, Leif Groop och Jonas Frisén ska driva de projekt som fick högst bidrag i årets bidragsutdelning inom medicin och hälsa.
-
Biolamina skaffar ny rådgivare
Stamcellsforskaren Stephen Minger ska ge stöd till labtechbolagets utveckling.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Släpper ny version av proteinatlasen
Idag lanseras en ny version av den karta över kroppens proteiner som satts samman genom det svenska miljardprojektet Human Protein Atlas, HPA.
-
GSK:s ebolavaccin får snabbspår i FDA
Nu inleder bolaget patientstudier i friska frivilliga.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Mingling do's and don'ts
Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, ...
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Diamyds vd går till Index
Från och med april ska Peter Zerhouni leda forskningsbolaget, som bland annat utvecklar läkemedel mot inflammatoriska tarmsjukdomar.
-
Orexo stämmer Actavis
Uppsalabolaget har inlämnat en stämningsansökan mot Actavis för patentintrång avseende Abstral i USA.
-
Grape extract kills cancer cells
Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
BREAKING